Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer

NCT00031863 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: rofecoxib
PROCEDURE: adjuvant therapy

Sponsor

Cancer Research Campaign Clinical Trials Centre